Skip to main navigation Skip to search Skip to main content

Combinatmarion treatment with Lactobacillus acidophilus LA-1, vitamin B, and curcumin ameliorates the progression of osteoarthritis by inhibiting the pro-inflammatory mediators

  • Jooyeon Jhun
  • , Hong Ki Min
  • , Hyun Sik Na
  • , Ji ye Kwon
  • , Jaeyoon Ryu
  • , Keun Hyung Cho
  • , Jeong Won Choi
  • , Kyoung Ah Jung
  • , Seon Yeong Lee
  • , Seok Jung Kim
  • , Chul Woo Yang
  • , Sung Hwan Park
  • , Mi La Cho
  • Catholic University of Korea
  • Konkuk University
  • The Catholic University of Korea
  • Impact Biotech

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

Disease-modifying osteoarthritis (OA) therapy is not yet available. Several adjuvant therapies have demonstrated promising results in the treatment of OA. The present study aimed to investigate the therapeutic effects and underlying mechanisms of a combination of Lactobacillus acidophilus, vitamin B, and curcumin in the treatment of OA. Monosodium iodoacetate (MIA)-induced arthritis of the knee joint in rat was used as an animal model of human OA. The combination of L. acidophilus LA-1, vitamin B, and curcumin or a saline solution was given orally. Pain was measured according to the paw withdrawal latency, and paw withdrawal threshold. Cartilage destruction was analyzed using histomorphological techniques and the Mankin scoring system. Protein expression in the joint was examined using immunohistochemistry. The effects of the combination of L. acidophilus LA-1, vitamin B, and curcumin on mRNA levels in chondrocytes stimulated with interleukin (IL)-1β were analyzed using real-time polymerase chain reaction. The combination of L. acidophilus, vitamin B, and curcumin effectively downregulated Th17 cells and the related cytokine IL-17, thereby maintained the Treg population, and increased the expression of the Treg-related cytokine IL-10 in human peripheral blood mononuclear cells. The OA animal model exhibited reduced pain and preservation of cartilage in response to the combination treatment. The expression levels of pro-inflammatory cytokines and the catabolic, matrix metalloproteinase-13 (MMP-13), were decreased, whereas the expression of the anabolic tissue inhibitors of metalloproteinases (TIMPs) were upregulated in response to the drug combination. The combination of L. acidophilus, vitamin B, and curcumin was beneficial in OA treatment, controlling the inflammatory response via regulation of the Th17/Treg population and reducing the expression of pro-inflammatory cytokines in human peripheral blood mononuclear cells. The combination treatment also preserved cartilage, suppressed osteoclastogenesis, and regulated the anabolic/catabolic imbalance. These findings indicate the therapeutic potential of combination use of L. acidophilus, vitamin B, and curcumin in patients with OA.

Original languageEnglish
Pages (from-to)112-121
Number of pages10
JournalImmunology Letters
Volume228
DOIs
StatePublished - Dec 2020

Bibliographical note

Publisher Copyright:
© 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Curcumin
  • Microbiota
  • Osteoarthritis
  • Osteoclastogenesis
  • Th17
  • Treg
  • Vitamin B

Fingerprint

Dive into the research topics of 'Combinatmarion treatment with Lactobacillus acidophilus LA-1, vitamin B, and curcumin ameliorates the progression of osteoarthritis by inhibiting the pro-inflammatory mediators'. Together they form a unique fingerprint.

Cite this